US Patent Issued to Aucentra Therapeutics on Aug. 26 for "Derivatives of 4-(imidazo[1,2-apyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as therapeutic agents" (Australian Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,132, issued on Aug. 26, was assigned to Aucentra Therapeutics Pty Ltd (Dulwich, Australia).

"Derivatives of 4-(imidazo[1,2-apyridin-3-yl)-n-(pyridinyl)pyrimidin-2-amine as therapeutic agents" was invented by Shudong Wang (Adelaide, Australia), Mingfeng Yu (Marden, Australia) and Yi Long (Campbelltown, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel class of heteroaryl compounds for use in the prevention and/or treatment of proliferative diseases and conditions including cancers. The compounds are considered to be capable of inhibiting cell proliferation by inhibiting the activity of FLT3 and its mutant forms and/or other protein kin...